-
1
-
-
0036270509
-
Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers
-
Akamatsu, T., Nakamura, N., Furuya, N., Shimizu, T., Gotou, A., Kiyosawa, K., Katsuyama, T., Osumi, T., Hirao, Y., and YMiyamoto, G. 2002. Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers. Dig. Dis. Sci., 47 (6): 1399-1404.
-
(2002)
Dig. Dis. Sci.
, vol.47
, Issue.6
, pp. 1399-1404
-
-
Akamatsu, T.1
Nakamura, N.2
Furuya, N.3
Shimizu, T.4
Gotou, A.5
Kiyosawa, K.6
Katsuyama, T.7
Osumi, T.8
Hirao, Y.9
YMiyamoto, G.10
-
2
-
-
0026619188
-
Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa
-
Ishihara, K., Komuro, Y., Nishiyama, N., Yamasaki, K., and Hotta, K. 1992. Effect of rebamipide on mucus secretion by endogenous prostaglandin- independent mechanism in rat gastric mucosa. Arziem.-Forch., 42 (12): 1462-1466.
-
(1992)
Arziem.-Forch.
, vol.42
, Issue.12
, pp. 1462-1466
-
-
Ishihara, K.1
Komuro, Y.2
Nishiyama, N.3
Yamasaki, K.4
Hotta, K.5
-
3
-
-
18044381610
-
Rebamipide
-
Yakugyo Jiho Co: Tokyo, Japan
-
Japan Pharmaceutical Information Center. 1997. Rebamipide. In Drugs in Japan; Ethical Drugs; Yakugyo Jiho Co: Tokyo, Japan, 1681-1682.
-
(1997)
Drugs in Japan; Ethical Drugs
, pp. 1681-1682
-
-
-
4
-
-
0029900094
-
Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis
-
Naito, Y., Yoshikawa, T., Iinuma, S., Miyazaki, R., Yagi, N., Yoshida, N., Osumi, T., Hirao, Y., and Kondo, M. 1996. Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis. Arzneim.-Forsch., 46 (7): 698-700.
-
(1996)
Arzneim.-Forsch.
, vol.46
, Issue.7
, pp. 698-700
-
-
Naito, Y.1
Yoshikawa, T.2
Iinuma, S.3
Miyazaki, R.4
Yagi, N.5
Yoshida, N.6
Osumi, T.7
Hirao, Y.8
Kondo, M.9
-
5
-
-
0026606194
-
Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies
-
Shah, V.P., Midha, K.K., Dighe, S., McGilveray, I.J., Skelly, J.P., Yacobi, A., Layloff, T., Viswanathan, C.T., Cook, C.E., McDowall, R.D., Pittman, K.A., and Spector, S. 1992. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm. Res., 9 (4): 588-592.
-
(1992)
Pharm. Res.
, vol.9
, Issue.4
, pp. 588-592
-
-
Shah, V.P.1
Midha, K.K.2
Dighe, S.3
McGilveray, I.J.4
Skelly, J.P.5
Yacobi, A.6
Layloff, T.7
Viswanathan, C.T.8
Cook, C.E.9
McDowall, R.D.10
Pittman, K.A.11
Spector, S.12
-
6
-
-
0024239001
-
High-performance liquid chromatographic procedure for the determination of a new anti-gastric ulcer agent, 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon- 4-yl]propionic acid, in human plasma and urine
-
Shioya, Y. and Shimizu, T. 1988. High-performance liquid chromatographic procedure for the determination of a new anti-gastric ulcer agent, 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid, in human plasma and urine. J. Chromatogr., 434: 283-287.
-
(1988)
J. Chromatogr.
, vol.434
, pp. 283-287
-
-
Shioya, Y.1
Shimizu, T.2
-
7
-
-
0023629705
-
Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat
-
Yamasaki, K., Kanbe, T., Chijiwa, T., Ishiyama, H., and Morita, S. 1987. Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur. J. Pharmacol., 142: 23-29.
-
(1987)
Eur. J. Pharmacol.
, vol.142
, pp. 23-29
-
-
Yamasaki, K.1
Kanbe, T.2
Chijiwa, T.3
Ishiyama, H.4
Morita, S.5
|